KAM
NBSE

Knightsbridge Asset Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Knightsbridge Asset Management’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,011
Closed -$8K – 142
2022
Q3 		$8K Sell
1,011
-106
-9% -$839 ﹤0.01% 119
2022
Q2 		$23K Buy
1,117
+591
+112% +$12.2K ﹤0.01% 118
2022
Q1 		$20K Buy
+526
New +$20K 0.01% 97